search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Improving antithrombotic treatment in atrial fibrillation


- candidate number21117
- NTR NumberNTR5002
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR5-dec-2014
- Secondary IDsN/A 
- Public TitleImproving antithrombotic treatment in atrial fibrillation
- Scientific TitleClinical Decision Support System for improving adherence to ESC guidelines for antithrombotic treatment in atrial fibrillation
- ACRONYM
- hypothesisThe use of a clinical decision support system will increase adherence to the ESC guideline for atrial fibrillation in terms of calculation of CHA2DS2-VASc score and HAS-BLED score, and the resulting accurate antithrombotic treatment.
- Healt Condition(s) or Problem(s) studiedAtrial Fibrillation, Prevention, Ischemic stroke
- Inclusion criteriaPatients: All patients with atrial fibrillation visisting one of the three selected hospitals in the Netherlands. Physicians: All cardiologists working in one of the three selected hospitals in the Netherlands (Franciscus Ziekenhuis Roosendaal, Lievensberg Ziekenhuis Bergen op Zoom, and Beatrixziekenhuis Gornichem).
- Exclusion criteriaN/A
- mec approval receivedno
- multicenter trialyes
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-jan-2015
- planned closingdate1-jul-2015
- Target number of participants0
- InterventionsA clinical decision support system integrated in the electronic health record (EHR) of the patient, that calculates the CHA2DS2-VASc score and HAS-BLED score based on the patient information stored in the EHR, and advises the physician regarding the antithrombotic treatment strategy to be followed, based on the ESC guidelines for atrial fibrillation. Two study arms will be used: An intervention group which received the clinical decision support system, integrated in the EHR, and a control group using the same EHR but without the clinical decision support system.
- Primary outcomeThe proportion of patients with non-valvular atrial fibrillation whose anti-thrombotic treatment prescription is in accordance with the ESC guideline for atrial fibrillation.
- Secondary outcomeN/A
- TimepointsAdherence will be measured at the end of the study.
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIES R.J. van Brummelen
- CONTACT for SCIENTIFIC QUERIES R.J. van Brummelen
- Sponsor/Initiator Academic Medical Center (AMC), Amsterdam
- Funding
(Source(s) of Monetary or Material Support)
- PublicationsN/A
- Brief summaryA clinical decision support system will be implemented in three hospitals in the Netherlands, integrated in the electronic health record. This system will alert the cardiologist about the CHA2DS2-VASc score and HAS-BLED score of a patient with atrial fibrillation, and suggests antithrombotic treatment based don the ESC guideline for atrial fibrillation. Two study arms will be used: an intervention arm using the EHR with the clinical decision support system, the control group with the same EHR, but without the clinical decision support system. The main outcomes will be the percentage of anti-thrombotic prescriptions in patients with atrial fibrillation according to the Dutch guideline.
- Main changes (audit trail)
- RECORD5-dec-2014 - 3-apr-2015


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl